Checking a simple stepping test for exercise capacity in peripheral artery disease
Examines whether a 6-minute stepper test measures exercise capacity reliably in peripheral artery disease.
Key facts
- Who runs it
- Gazi University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Validity and Reliability of the 6-minute Stepper Test in Patients With Peripheral Artery Disease
- Status
- Recruiting
- People taking part
- 24 people, planned
- Started
- 24 Sept 2025
- Planned end
- 24 Jul 2026
- Type of study
- Observational
- Record updated
- 3 February 2026
Who can take part
The trial is looking for adults with peripheral artery disease (narrowed leg arteries) to test whether a 6-minute stepper test measures exercise ability reliably.
- Age
- 18 to 80 years
- Sex
- All sexes
- Disease stage
- Peripheral artery disease diagnosed by the Department of Cardiovascular Surgery. The disease must be stable, in remission and under follow-up.
- Earlier treatment
- People who had an amputation because of poor blood flow cannot join. People who had major surgery in the last 3 months cannot join.
- Biomarker or test result
- Ankle-brachial index (ABI) ≤1.40, or exercise ABI ≤0.73, or a diagnosis of calcified blood vessels.
- Main reasons for not taking part
- Unstable coronary artery disease, or a heart attack in the last 3 months
- Uncontrolled diabetes, lung disease or an acute infection
- Weight over 110 kg (243 lb), the limit of the stepper device
- Reasons not to do exercise testing, as listed by the American Sports Medicine Association
- Pregnant or breastfeeding women
Show the full registry criteria (15)Hide the full registry criteria
Who can take part
- Diagnosed with peripheral artery disease by the Department of Cardiovascular Surgery,
- Ankle-brachial index (ABI) ≤1.40 or exercise ABI ≤0.73 or diagnosed with calcified vascular response, in remission and under follow-up,
- Stable,
- Ages between 18 and 80,
- Patients who volunteer to participate in the study will be included
Who cannot take part
- Previously underwent ischaemic amputation,
- Unstable coronary artery disease,
- Uncontrolled Diabetes Mellitus,
- Pulmonary disease,
- Acute infection,
- Patients with PAD who have undergone major surgery or had a myocardial infarction within the last 3 months
- Patients will be excluded if they have:
- Weight >110 kg because it is the upper limit of the stepper device,
- Contraindications to exercise testing per the American Sports Medicine Association,
- Pregnant and breastfeeding women,
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Peripheral artery disease
This trial is currently available in Türkiye.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Hemodynamic dysfunction and decreased blood flow to the extremities negatively affect patients' muscle oxygenation, balance, claudication pain, lower extremity muscle strength, and arterial stiffness. These negatively affect patients' exercise capacity. The six-minute stepper test (6 MST) is a simple, low-cost, and minimal space requirement assessment method used to evaluate functional exercise capacity and is known to be valid and reliable for various pulmonary and cardiovascular diseases. However, it is not known whether the 6 MST is valid and reliable in assessing functional exercise capacity in patients with PAD. It is known that muscle oxygen levels, balance levels, intermittent claudication, lower extremity muscle strength, and arterial stiffness have negative effects on exercise capacity. However, the extent to which these variables affect the 6 MST is unknown. The primary aim is to examine the validity and reliability of the 6 MST in patients with PAD. The secondary aim is to evaluate arterial stiffness, muscle oxygen levels, intermittent claudication, static and dynamic balance levels, lower extremity muscle strength, and examine their effects on the 6 MST.
The group in the trial
- Patients With Peripheral Artery Disease
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Examination of the Validity and Reliability of 6-minute Stepper Test in Patients With Peripheral Artery Disease
- Plain-language title
- Checking a simple stepping test for exercise capacity in peripheral artery diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT07169045, who can take part
- Record updated
- 3 February 2026